Citigroup Maintains Buy on Sotera Health, Raises Price Target to $25
Benzinga Newsdesk 2 months ago
NewsPrice TargetAnalyst Ratings
Citigroup analyst Brendan Digan maintains Sotera Health (NASDAQ:SHC) with a Buy and raises the price target from $23 to $25.
Citigroup analyst Brendan Digan maintains Sotera Health (NASDAQ:SHC) with a Buy and raises the price target from $23 to $25.